141 related articles for article (PubMed ID: 10997587)
1. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21CIP1 in leukemic cell (U937) differentiation induced by low concentrations of 1-beta-D-arabinofuranosylcytosine.
Wang Z; Wang S; Fisher PB; Dent P; Grant S
Differentiation; 2000 Aug; 66(1):1-13. PubMed ID: 10997587
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S
Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557
[TBL] [Abstract][Full Text] [Related]
3. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S
Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354
[TBL] [Abstract][Full Text] [Related]
4. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
5. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
6. Evidence of a functional role for the cyclin-dependent kinase-inhibitor p21WAF1/CIP1/MDA6 in promoting differentiation and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937).
Rosato RR; Wang Z; Gopalkrishnan RV; Fisher PB; Grant S
Int J Oncol; 2001 Jul; 19(1):181-91. PubMed ID: 11408941
[TBL] [Abstract][Full Text] [Related]
7. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation.
Vrana JA; Kramer LB; Saunders AM; Zhang XF; Dent P; Povirk LF; Grant S
Biochem Pharmacol; 1999 Jul; 58(1):121-31. PubMed ID: 10403525
[TBL] [Abstract][Full Text] [Related]
9. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
Rosato RR; Almenara JA; Grant S
Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953
[TBL] [Abstract][Full Text] [Related]
10. Effects of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation and drug-mediated apoptosis in human myeloid leukemia cells (HL-60).
Freemerman AJ; Vrana JA; Tombes RM; Jiang H; Chellappan SP; Fisher PB; Grant S
Leukemia; 1997 Apr; 11(4):504-13. PubMed ID: 9096690
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53.
Vrana JA; Decker RH; Johnson CR; Wang Z; Jarvis WD; Richon VM; Ehinger M; Fisher PB; Grant S
Oncogene; 1999 Nov; 18(50):7016-25. PubMed ID: 10597302
[TBL] [Abstract][Full Text] [Related]
12. Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.
Rao AS; Freemerman AJ; Jarvis WD; Chelliah J; Bear HD; Mikkelsen R; Grant S
Leukemia; 1996 Jul; 10(7):1150-8. PubMed ID: 8683995
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
Chelliah J; Freemerman AJ; Wu-Pong S; Jarvis WD; Grant S
Biochem Pharmacol; 1997 Sep; 54(5):563-73. PubMed ID: 9337072
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in human leukemia cells by the CDK1 inhibitor CGP74514A.
Dai Y; Dent P; Grant S
Cell Cycle; 2002; 1(2):143-52. PubMed ID: 12429924
[TBL] [Abstract][Full Text] [Related]
15. The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cells.
Rosato RR; Almenara JA; Cartee L; Betts V; Chellappan SP; Grant S
Mol Cancer Ther; 2002 Feb; 1(4):253-66. PubMed ID: 12467221
[TBL] [Abstract][Full Text] [Related]
16. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
Wang S; Wang Z; Grant S
Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556
[TBL] [Abstract][Full Text] [Related]
17. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells.
Yamato K; Koseki T; Ohguchi M; Kizaki M; Ikeda Y; Nishihara T
Mol Endocrinol; 1997 Jul; 11(8):1044-52. PubMed ID: 9212052
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of p21Cip1 or p27Kip1 in the promyelocytic leukemia cell line HL60 accelerates its lineage-specific differentiation.
Zhou P; Yao Y; Soh JW; Weinstein IB
Anticancer Res; 1999; 19(6B):4935-45. PubMed ID: 10697493
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial damage and apoptosis in human leukemia cells (U937) overexpressing bcl-2 by the kinase inhibitor 7-hydroxystaurosporine (UCN-01).
Tang L; Boise LH; Dent P; Grant S
Biochem Pharmacol; 2000 Nov; 60(10):1445-56. PubMed ID: 11020446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
